Prevalence of human papillomavirus in esophageal carcinoma in Tangshan, China

doi:10.3748/wjg.v21.i10.2905

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7784)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

439

WORD

244

HTML

4816

Figures (1-4)

223

Tables (1-2)

228

Sum=5950

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

746

Download

1088

Sum=1834

Mar 14, 2015 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 14, 2015; 21(10): 2905-2911
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2905

Table 1 Primers used in PCR amplification of human papillomavirus DNA

Primer	Sequence, 5’-3’	Annealing temperature,°C	PCR product, bp
PC04	CAACTTCATCCACGTTCACC	62	150
GH20	GAAGAGCCAAGGACAGGTAC	62	150
GP5+	TTTGTTACTGTGGTAGATACTAC	55	150
GP6+	CTTATACTAAATGTCAAATAAAAAG	55	150
HPV16E6F	CAACAAGACATACATCGACC	60	350
R	CAACAAGACATACATCGACC	60	350
HPV18E6F	CACTTCACTGCAAGACATAGA	55	350
R	GTTGTGAAATCGTCGTTTTTCA	55	350

Table 2 Polymerase chain reaction detection frequency of human papillomavirus using different primers

Primer set	Tested cases, n	Positive cases, n	Positive cases
PC04/GH20	198	196	> 98.00%
GP5+/GP6+	198	158	79.79%
HPV 16	198	80	40.40%
HPV 18	198	94	47.47%
GP+ and HPV16/18-¹	198	13	6.50%
HPV 16 and 18	198	55	27.77%
HPV 16 or 18	198	119	60.10%
GP and HPV 16 and 18	198	48	24.24%
GP+/HPV16+/HPV18+²	198	185	93.00%

¹GP5+/GP6+ positive but human papillomavirus (HPV) 16/18 negative;

²GP5+/GP6+ positive or HPV 16 positive or HPV 18 positive.

Citation: Mehryar MM, Li SY, Liu HW, Li F, Zhang F, Zhou YB, Zeng Y, Li JT. Prevalence of human papillomavirus in esophageal carcinoma in Tangshan, China. World J Gastroenterol 2015; 21(10): 2905-2911
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2905.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i10.2905